Dentistry and the myasthenia gravis patient: a review of the current state of the art

被引:7
作者
Patil, Pavan M. [1 ]
Singh, Gurjap [1 ]
Patil, Seema P.
机构
[1] Sharda Univ, Sch Dent Sci, Dept Oral & Maxillofacial Surg, Greater Noida, Uttar Pradesh, India
来源
ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY | 2012年 / 114卷 / 01期
关键词
LOW-DOSE TACROLIMUS; MYCOPHENOLATE-MOFETIL; REFRACTORY MYASTHENIA; RECEPTOR ANTIBODIES; CLINICAL-FEATURES; FOLLOW-UP; AUTOIMMUNE; THYMECTOMY; DISORDERS; RITUXIMAB;
D O I
10.1016/j.tripleo.2011.08.023
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Myasthenia gravis(MG) is a chronic neuromuscular disease characterized by muscular weakness and fatigability. Dental management of patients diagnosed with MG presents a challenge to the oral health care provider. The purpose of this article was to review the etiology, pathogenesis, diagnosis, and clinical signs and symptoms associated with MG, highlighting the role of the oral health care provider in the process of diagnosis and management of the oral and dental complications that might be associated with the disease, while avoiding myasthenic crisis. A discussion of the recent approaches to treatment of the disease and current research on MG is presented.(Oral Surg Oral Med Oral Pathol Oral Radiol 2012;114:e1-e8)
引用
收藏
页码:E1 / E8
页数:8
相关论文
共 83 条
  • [1] Interleukin-10 promoter polymorphisms in myasthenia gravis
    Alseth, Espen Homleid
    Nakkestad, Hanne Linda
    Aarseth, Jan
    Gilhus, Nils Erik
    Skeie, Geir Olve
    [J]. JOURNAL OF NEUROIMMUNOLOGY, 2009, 210 (1-2) : 63 - 66
  • [2] AMPICILLIN MAY AGGRAVATE CLINICAL AND EXPERIMENTAL MYASTHENIA-GRAVIS
    ARGOV, Z
    BRENNER, T
    ABRAMSKY, O
    [J]. ARCHIVES OF NEUROLOGY, 1986, 43 (03) : 255 - 256
  • [3] GLUCOCORTICOSTEROIDS IN DENTISTRY
    BAHN, SL
    [J]. JOURNAL OF THE AMERICAN DENTAL ASSOCIATION, 1982, 105 (03) : 476 - 481
  • [4] BASSLER R, 1987, PATHOL RES PRACT, V182, P87
  • [5] Therapy of myasthenic crisis
    Berrouschot, J
    Baumann, I
    Kalischewski, P
    Sterker, M
    Schneider, D
    [J]. CRITICAL CARE MEDICINE, 1997, 25 (07) : 1228 - 1235
  • [6] Extracorporeal Immunoglobulin Elimination for the Treatment of Severe Myasthenia Gravis
    Blaha, M.
    Pit'ha, J.
    Blaha, V.
    Lanska, M.
    Maly, J.
    Filip, S.
    Langrova, H.
    [J]. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY, 2010,
  • [7] Myasthenia gravis and tumours of the thymic region - Report of a case in which the tumor was removed
    Blalock, A
    Mason, MF
    Morgan, HJ
    Riven, SS
    [J]. ANNALS OF SURGERY, 1939, 110 : 544 - 561
  • [8] MANAGEMENT OF PATIENTS WITH MYASTHENIA-GRAVIS WHO REQUIRE MAXILLARY DENTURES
    BOTTOMLEY, WK
    TEREZHALMY, GT
    [J]. JOURNAL OF PROSTHETIC DENTISTRY, 1977, 38 (06) : 609 - 614
  • [9] CALCATERRA T C, 1972, Transactions of the American Academy of Ophthalmology and Oto-Laryngology, V76, P308
  • [10] Results of transcervical thymectomy for myasthenia gravis in 100 consecutive patients
    Calhoun, RF
    Ritter, JH
    Guthrie, TJ
    Pestronk, A
    Meyers, BF
    Patterson, GA
    Pohl, MS
    Cooper, JD
    [J]. ANNALS OF SURGERY, 1999, 230 (04) : 555 - 559